Bone Biologics Corp (BBLG)

Nasdaq: BBLG · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Burlington, MA · filing with the SEC since 2008

Full chart Alerts Compare

Grade4.4

◀ Past 2.8● Present 5.2▶ Future 4.9

5 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2020, as filed

Revenue$1.07B0.0%

Net income-$1.8M+46.7%

Earnings per sharen/a

Operating cash flow-$426,933+86.9%

Cashn/a

Debtn/a

Shareholders’ equity-$13.7M-15.4%

Shares, dilutedn/a

Return on equity-57.8%

The recordfrom its filings

Filings in 202629

Newest filingNov 10 · SCHEDULE 13G/A

Annual reportMar 2, 2026

Quarterly reportOct 26, 2026

Next report due10-K by Mar 31

Insider sales, 12 months$0.00

Insider buys, 12 months$0.00

Patents grantedn/a

Filer categoryNon-accelerated filer<br>Smaller reporting company

Trailing twelve months to Sep 2026Net income -$2.8MCash from operations -$2.6Mthe four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

16171819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 10, 2026 · SEC EDGAR · Form SCHEDULE 13G/A

Large holder update, amended

Open the filing on sec.gov

Oct 26, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

Oct 13, 2026 · SEC EDGAR · Form 25-NSE

Delisting notice from the exchange

Open the filing on sec.gov

Sep 30, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 30, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 30, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 30, 2026 · SEC EDGAR · Form 4

Insider trade report

Open the filing on sec.gov

Sep 29, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Sep 16, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Aug 28, 2026 · SEC EDGAR · Form DEF 14A

Proxy statement

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

Bone Biologics Corp is classed by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies (industry code 3842), based in Burlington, MA.

Newest on the record

Large holder update, amended on Nov 10. Before it, quarterly report on Oct 26.

What is due next

The 10-K for the period to Dec 31, 2026, due by Mar 31, 2027.

About BBLG

Bone Biologics Corp is classed by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies (industry code 3842), based in Burlington, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $3.1 million (its filed statements).

IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

HeadquartersBurlington, MA

Business modelProduct business

ExchangeNasdaq

Filing since2008

Fiscal year endsDec 31

SEC number (CIK)1419554

Peers on fileHSCS, NTRB, RGNT, MLSS

Who runs it

Financial performance

In fiscal 2020 Bone Biologics’s revenue was $1.07 billion, unchanged from $1.07 billion the year before. It made a net loss of $1.82 million.

Annual report, filed Mar 2, 2026.

Financial statements

The grade

Bone Biologics grades 4.4 of 10 against its own industry, the 29 companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies. Four of the nine metrics are read as filed and five are SI estimates, each with its reasoning.

◀ Past2.8

● Present5.2

▶ Future4.9

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton BBLG · research, not advice